Author: Russell, Beth; Moss, Charlotte; Rigg, Anne; Van Hemelrijck, Mieke
Title: COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Document date: 2020_3_30
ID: 0uengr9t_5
Snippet: One study within the review linked SARS-CoV to the downregulation of ACE2 [1] . This downregulation of ACE2 has previously been implicated in the loss of pulmonary function in SARS-CoV [1] . However, further data also suggested that ACE2 expression is increased through the use of ibuprofen, in diabetic patients and in those treated with angiotensin II type-I receptor blockers [2] . Consequently, it was suggested that increased expression of ACE2 .....
Document: One study within the review linked SARS-CoV to the downregulation of ACE2 [1] . This downregulation of ACE2 has previously been implicated in the loss of pulmonary function in SARS-CoV [1] . However, further data also suggested that ACE2 expression is increased through the use of ibuprofen, in diabetic patients and in those treated with angiotensin II type-I receptor blockers [2] . Consequently, it was suggested that increased expression of ACE2 in these co-morbid patients could facilitate infection with COVID-19.
Search related documents:
Co phrase search for related documents- angiotensin II type and pulmonary function: 1
- angiotensin II type and receptor blocker: 1, 2, 3, 4, 5, 6, 7
- co morbid patient and SARS CoV link: 1
- increase expression and infection facilitate: 1, 2, 3
- increase expression and pulmonary function: 1, 2
- increase expression and receptor blocker: 1, 2, 3, 4, 5
- increase expression and SARS CoV link: 1
- infection facilitate and receptor blocker: 1
- infection facilitate and SARS CoV link: 1, 2
- pulmonary function and SARS CoV link: 1
Co phrase search for related documents, hyperlinks ordered by date